Press release: Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study
Ncardia Launches Panel of Ready-to-Use Assays to Streamline Screening and Selection of New Therapeutic Candidates
Ncardia Acquires STAR-CRISPR Technology for Advanced Gene Editing of iPSCs
Unveiling Ncardia's Path to Innovation and Growth
The Urgent Need for Reliable Cell Models in ALS Research
Ncardia @ ASGCT 24: The latest updates from Baltimore
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
